Colorectal cancer, also known as colon cancer or rectal cancer, affects the colon and the rectum. There are several screening tests, kits, and medical devices used for the diagnosis of colorectal cancer. Primary causes of colorectal cancer are lifestyle disorders, aging, and diet. Moreover, colorectal cancer is a leading cause of cancer incidence and mortality among adults younger than 50 years in the US.
The colorectal cancer diagnostics market is driving due increasing incidence and prevalence of colorectal cancer, and technological advancements in radiology and chemotherapy. However, the high costs of diagnostic methods and lack of awareness in low income countries is expected to hamper the growth of the global colorectal cancer diagnostics market. Moreover, increasing government efforts to reduce mortality of colorectal cancer in developing economies is anticipated to drive demand the growth of the market for colorectal cancer diagnostics market.
The "Colorectal Cancer Diagnostics Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of colorectal cancer diagnostics market with detailed market segmentation by modality, and user. The colorectal cancer diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in colorectal cancer diagnostics market and offers key trends and opportunities in the market.
The colorectal cancer diagnostics market is segmented on the basis of modality, and end user. Based on modality, the market is segmented into diagnostics techniques, and therapeutics. Diagnostics Techniques is further sub segmented into stool tests, immunohistochemistry, colonoscopy, flexible sigmoidoscopy, and other diagnostics techniques. Therapeutics is further sub segmented into chemotherapy, immunotherapy, and others. Based on end user, the market is segmented into hospitals, diagnostic laboratories, and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the colorectal cancer diagnostics market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The colorectal cancer diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting colorectal cancer diagnostics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the colorectal cancer diagnostics market in these regions.
Get more information on this report :
The report covers key developments in the colorectal cancer diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Colorectal Cancer Diagnostics market are anticipated to have lucrative growth opportunities in the future with the rising demand for colorectal cancer diagnostics market in the global market. Below mentioned is the list of few companies engaged in the colorectal cancer diagnostics market.
The report also includes the profiles of key players in colorectal cancer diagnostics market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
F. Hoffmann-La Roche AG
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Get more information on this report :
The List of Companies
1. Abbott Laboratories
2. Amgen Inc.
3. Clinical Genomics
4. EDP Biotech
5. Epigenomics AG
6. F. Hoffmann-La Roche AG
7. Quest Diagnostics
8. Novigenix SA
9. Siemens Healthineers